A higher body mass index (BMI) and recent exposure to certain antibiotics are risk factors for asymptomatic intestinal colonization with…
Articles by Andrea Lobo, PhD
Despite widespread use of telehealth, fewer cystic fibrosis (CF) patients in the U.S. met the recommendations for routine follow-up…
First Wave Biopharma has selected the initial sites for the Phase 2 clinical trial of a new adrulipase formulation…
The U.K. National Institute for Health and Care Research awarded £1.5 million (about $1.8 million) for research on an at-home…
A 30-year-old woman with cystic fibrosis (CF) and poor lung function gave birth to a healthy child while being…
The Phase 2a clinical trial testing Aridis Pharmaceuticals’ experimental inhaled therapy AR-501 for chronic lung infections in people with…
The antibiotic Xenleta (lefamulin) was well tolerated in a Phase 1 clinical trial in adults with cystic fibrosis…
The Cold Spring Harbor Laboratory (CSHL) has licensed an artificial intelligence platform, developed by Epistemic AI, to accelerate…
Acne might be a side effect of Trikafta therapy in cystic fibrosis (CF) patients, according to a new case…
Use of Kaftrio (elexacaftor, tezacaftor, and ivacaftor), sold in the U.S. as Trikafta, helped a woman with cystic fibrosis (CF)…